MedWatch

This is how EMA chooses its new executive director

Thursday, two candidates face their perhaps most important exam to date, when they have to convince the European Medicines Agency that they should be the agency's new executive director. DMA's director general, Thomas Senderovitz, sits on the board of the EMA and he provides and insight into the process before, during and after.

Thomas Senderovitz, director general of the Danish Medicines Agency, will Thursday help select the new director general of the European Medicines Agency. Photo: Lægemiddelstyrelsen / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles